Metabolic and neurodegenerative disorders across the lifespan

Principles and Practice of Lifespan Developmental Neuropsychology

Volumn , Issue , 2010, Pages 427-448

  Ziegler, Richard ^a   Shapiro, Elsa ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955959509     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511674815.033     Document Type: Chapter

References (87)

1. Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2001.
2. Bjoraker K, Delaney K, Peters C, Krivit W, Shapiro E. Long term outcomes of adaptive functions for children with MPS I. J Dev Behav Pediatr 2006;27:290-6.
3. Shapiro E, Krivit W, Lockman L, Jambaque I, Peters C, Cowan M, et al. Long-term beneficial effect of bone marrow transplantation for childhood onset cerebral X-linked adrenoleukodystrophy. Lancet 2000;356:713-18.
4. Peters C, Charnas L, Tan Y, Ziegler R, Shapiro E, DeFor T, et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 2004;104:881-8.
5. Peters C, Shapiro E, Anderson J, Henslee-Downey J, Klemperer M, Cowan M, et al. Hurler Syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. Blood 1998;91:2601-8.
6. Peters C, Balthazor M, Shapiro E, King R, Kollman C, Hegland J, et al. Outcome of unrelated donor bone marrow transplantation in forty children with Hurler syndrome. Blood 1996;87:4894-902.
7. Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol 1991;5:125-42.
8. Benedict RHB, Schretlen D, Groninger L, Dobraski M, Shpritz, B. Revision of the Brief Visuospatial Memory Test: studies of normal performance, reliability, and validity. Psychol Assess 1996;8:145-53.
9. Sirois P, Posner M, Stehbens JA, Loveland KA, Nichols S, Donfield SM, et al. Hemophilia Growth and Development Study. Quantifying practice effects in longitudinal research with the WISC-R and WAIS-R: A study of children and adolescents with hemophilia and male siblings without hemophilia. J Ped Psychol 2002;27:121-31.
10. Salthouse TA, Berish DE. Correlates of within-person (across-occasion) variability in reaction time. Neuropsychology 2005;19:77-87.
11. Fuentes K, Hunter MA, Strauss E, Hultsch DF. Intraindividual variability in cognitive performance in persons with chronic fatigue syndrome. Clin Neuropsychol 2001;15:210-27.
12. Strauss E, Hultsch DF, Hunter M, Slick DJ, Patry B, Levy-Bencheton J. Using intraindividual variability to detect malingering in cognitive performance. Clin Neuropsychol 1999;13:420-32.
13. Strauss E, MacDonald S, Hunter M, Moll A, Hultsch DF. Intraindividual variability in cognitive performance in three groups of older adults: cross-domain links to physical status and self-perceived affect and beliefs. J Int Neuropsych Soc 2002;8:893-906.
14. Macdonald S, Hultsch DF, Bunce D. Intraindividual variability in vigilance performance: does degrading visual stimuli mimic age-related “neural noise”?’ J Clin Exp Neuropsychol 2006;28:655-75.
15. Russell VA, Oades, RD, Tannock R, Killeen PR, Auerbach JG, Johansen EB, Sagvolden T. Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis. Behav Brain Funct 2006;2:30.
16. Goldman D, Shapiro E, Nelson CA. Measurement of vigilance in 2-year old children. Dev Neuropsychol 2004;25:227-50.
17. Jordan C, Hughes S, Johnson A, Shapiro E. The Color Object Association Test (COAT): the development of a new measure of declarative memory for 18 to 36 month- old toddlers. Child Neuropsychol 2008;14:21-41.
18. Roid, Gale H. Stanford Binet Intelligence Scale, 5th edn., Rolling Meadows, IL: Riverside; 2003.
19. Wechsler D. Wechsler Intelligence Scale for Children. Fourth Edition. San Antonio, TX: Harcourt Assessments; 2003.
20. Mullen E. The Mullen Scales ofEarly Learning. Bloomington, MN: Pearson Assessments; 1995.
21. Bayley N. Bayley Scales of Infant Development II. San Antonio, TX: Harcourt Assessments; 1993.
22. Shapiro E, Balthazor M. Metabolic and neurodegenerative disorders of childhood. In Taylor G. Ris D, Yeates K, eds. Pediatric Neuropsychology: Research, Theory and Practice. New York: Guilford Press; 2001: 171-205.
23. Charnas L, Ziegler R, Shapiro E. Pediatric chronic disease. In Rizzo M, Eslinger P, eds. Principles and Practice of Behavioral Neurology and Neuropsychology. Philadelphia, PA: Saunders; 2004: 983-99.
24. Martin HR, Poe MD, Reinhartsen D, Pretzel RE, Roush J, Rosenberg A, Dusing SC, Escolar, M. Methods for assessing neurodevelopment in lysosomal storage diseases and related disorders: a multidisciplinary perspective. Acta Pxdiatr 2008;97:69-75.
25. Kempen J, Kritchevsky M, Feldman ST. Effect of visual impairment on neuropsychological test performance. J Clin Exp Neuropsychol 1994;16:223-31.
26. Das JP, Ojile E. Cognitive processing of students with and without hearing loss. J Spec Educ 1995;29:323-36.
27. Krivit W, Lockman L, Watkins P.A, Hirsch J, Shapiro E. The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. JInher Metab Dis 1995;18:398-412.
28. Ashworth JL, Biswas S, Wraith E, Lloyd IC. Mucopolysaccharidoses and the eye. Survey Ophthal 2006;51:1-17.
29. Sakai S, Hirayama K, Ogura K, Sakai N, Sudoh M, Murata N, Iwasaki S. Visual function of a patient with advanced adrenoleukodystrophy: comparison of luminance and color contrast sensitivities. Brain Dev 2008;30:68-72.
30. Baumann N, Turpin J-C, Lefevre M, Colsch B. Motor and psycho-cognitive clinical types in adult metachromatic leukodystrophy: genotype/phenotype relationships. J Physiol Paris 2002;96:301-6.
31. Shapiro E, Lipton M, Krivit W. White matter dysfunction and its neuropsychological correlates: a longitudinal study of a case of metachromatic leukodystrophy treated with bone marrow transplant. J Clin Exp Neuropsychol 1992;14:610-24.
32. Shapiro E, Thrall M, Peters C, Krivit W. Language, hearing loss, and mental development in Hurler syndrome. J Int Neuropsychol Soc 2000;6:161(Abstract).
33. Oz G, Tkac I, Charnas L, Choi I-Y, Bjoraker K. Shapiro E, Gruetter R. Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients. Neurology 2005;64:434-41.
34. Schneider JFL, Il’yansov KA, Boltshauser E, Henniga J, Martin E. Diffusion tensor imaging in cases of adrenoleukodystrophy: preliminary experience as a marker for early demyelination? Am J Neuroradiol 2003;24:819-24.
35. Nelson J, Crowhurst J, Carey B, Greed L. Incidence of the mucopolysaccharidoses in Western Australia. Am J Med Genet 2003;123A:310-13.
36. Whitley C, Draper KA, Dutton CM, Brown PA, Severson SL, France LA. Diagnostic test for mucopolysaccharidosis. II. Rapid quantification of glycosaminoglycan in urine samples collected on a paper matrix. Clin Chem 1989;35:2074-81.
37. Neufeld EF, Muenzer J. The mucopolysaccharidoses. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2001: 3421-52.
38. Whitley CB. The mucopolysaccharidoses. In Moser HW, ed. Neurodystrophies and Neurolipidoses, vol. 22 of Handbook of Clinical Neurology. Amsterdam: Elsevier; 1996: 281-328.
39. Muenzer J. The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations. J Pediatr 2004;144:S27-34.
40. Sparrow S, Cicchetti D, Balla D. Vineland Adaptive Behavior Scales, 2nd edn. Bloomington, MN: Pearson Assessments; 1984.
41. Bzoch K, League R, Brown V. Receptive-Expressive Emergent Language Scale, 3rd edn. Austin, TX: Pro-Ed; 2003.
42. Ireton, H. Child Development Inventory (CDI). Minneapolis, MN: Behavior Science Systems; 1992.
43. Zimmerman I, Steiner V, Pond R. Preschool Language Scale, 4th edn. San Antonio, TX: Harcourt Assessment; 2002.
44. Krivit W, Sung J, Shapiro E, Lockman L. Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases. Cell Transpl 1995;4:385-92.
45. Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P, et al. Cord-blood transplants from unrelated donors in patients with Hurler’s syndrome. NEngl J Med 2004;350:1960-9.
46. Souillet G, Guffon N, Maire I, Pujol M, Taylor P, Sevin F, et al. Outcome of 27 patients with Hurler’s syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transpl 2003;31:1105-17.
47. Tolar J, Grewal S, Bjoraker K, Whitley C, Shapiro E, Charnas L, Orchard P. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome. Bone Marrow Transpl 2007;41:531-5.
48. Wraith JE, Beck M, Lane R, vander Ploeg A, Shapiro E, Guffon, N. Enzyme replacement therapy for mucopolysaccharidosis I patients less than 5 years old: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase). Pediatrics 2007;120: e37-46.
49. Matheus G, Castillo M, Smith JK, Armao D, Towle D, Muenzer J. Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 2004;46:666-72.
50. Walkley SU. Secondary accumulation of gangliosides in lysosomal storage disorders. Semin Cell Dev Biol 2004;15:433-44.
51. Karachunski P, Clark B, Shapiro E. Distribution of lysosomal storage in the CNS neurons in patients with Mucopolysaccharidosis Type I. In Proceedings of the 1st annual WORLD symposium of the Lysosomal Disease Network, Minneapolis, MN: May 2004: 33.
52. Greenberg L. The Test of Variables of Attention (T.O.V.A.). Los Alamitos, CA: The TOVA Company; 1996.
53. Vijay S, Wraith JE. Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I. Acta Paediatr 2005;94:872-7.
54. Elkin TD, Megason G, Robinson A, Bock H-GO, Schrimsher G, Muenzer J. Longitudinal neurocognitive outcome in an adolescent with Hurler-Scheie syndrome. Neuropsychiatr Dis Treat 2006;2:381-6.
55. Bjoraker K, Charnas L, Whitley CB, Delaney K, Shapiro E. Neuropsychological function in attenuated MPS I: possible decline of memory and visual spatial function. In Proceedings of the International Neuropsychological Society meetings; Boston, MA: February 2006: 144.
56. Shapiro E, Thomas K, Guler E, Delaney K, Bjoraker K, Whitley C, Charnas L. Neuroimaging and neuropsychological function and neuroimaging in severe and attenuated mucopolysaccharidosis I. In Proceedings of the 4th WORLD symposium of the Lysosomal Disease Network, Mol Gen Metab 20; Las Vegas, NV: Feb 2008; 32.
57. Kakkis E, McEntee M, Vogler C, Le S, Levy B, Belichenko P, Passage M. et al. Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I. Mol Gen Metab 2004;83:163-74.
58. Martin R, Beck M, Eng C, Giugliani R, Harmatz P, Munoz V, Muenzer J. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 2008;121:e377-86.
59. Muenzer J, Wraith JE, Beck M, Giugliani R, Harmatz P, Eng C, et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Gen Med 2006;8:465-73.
60. Barone R, Nigro F, Triulzi F, Musumeci S, Fiumara A, Pavone L. Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome). Neuropediatrics 1999;30:270-4.
61. Colville GA, Watters JP, Yule W, Bax M. Sleep problems in children with Sanfilippo syndrome. Dev Med Child Neurol 1996;38:538-44.
62. Potegal M, Shapiro E. Delineation of the MPS III behavioral phenotype. In Proceedings of the 4th annual WORLD symposium of the Lysosomal Disease Network, Mol Gen Metab 20; Las Vegas, NV: Feb 2008;11.
63. Klein K, Krivit W, Whitley C, Peters C, Cool VA, Fuhrman M, et al. Poor cognitive outcome of nine children with Sanfilippo Syndrome following after bone marrow transplantation and successful engraftment. Bone Marrow Transpl 1995;15:S17681.
64. Harmatz P, Giugliani R, Schwartz I, Guffon N, Teles EL, Miranda MC, et al. Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. MPS VI Phase 3 Study Group. J Pediatr 2006;148:533-9.
65. Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 1997;120:1485-508.
66. Moser HW, Moser AB, Smith KD, Bergin A, Borel J, Shankroff J. Adrenoleukodystrophy: phenotypic variability and implications. J Inherit Metab Dis 1992;15:645-64.
67. Weller M, Liedtke W, Petersen D, Opitz H, Poremba M. Very-late-onset adrenoleukodystrophy: possible precipitation of demyelination by cerebral contusion. Neurology 1992;42:367-70.
68. Shapiro E, Lockman L, Balthazor M, Krivit W. Neuropsychological outcomes in several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 1995;18:413-29.
69. Tolar J, Orchard PJ, Bjoraker KJ, Ziegler RS, Shapiro EG, Charnas L. N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy. Bone Marrow Transpl 2007;39:211-15.
70. Loes DJ, Hite S, Moser H, Stillman AE, Shapiro E, Lockman, L, el al. Adrenoleukodystrophy: a scoring method for brain MR observation. Am J Neuroradiol 1994;15:1761-6.
71. Balthazor M, Rajanayagam V, Shapiro, E, Loes D, Stillman, A, Lockman, L et al. Predicting dementia in white matter disease: magnetic resonance imaging, magnetic resonance spectroscopy, and neuropsychology (Abstract). Ann Neurol 1995;40;290.
72. Rajanayagam V, Grad J, Krivit W, Loes, DJ, Lockman L, Balthazor M, et al. Proton MR spectroscopy of childhood adrenoleukodystrophy. Am J Neuroradiol 1996;17:1013-24.
73. Schneider JF, Il’yansov KA, Boltshauser E, Hennig J, Martin E. Diffusion tensor imaging in cases of adrenoleukodystrophy: preliminary experience as a marker for early demyelination? Am J Neuroradiol 2003;24:819-24.
74. Gieselmann V, Zlotogora J, Harris A, Wenger D, Morris CP. Molecular genetics of metachromatic leukodystrophy. Hum Mutat 1994;4:233-43.
75. Wenger DA, Coppola S, Liu, S-L Insights into the diagnosis and treatment of lysosomal storage diseases. Arch Neurol 2003;60:322-8.
76. Shapiro E, Lockman, LA, Knopman D, Krivit, W. Characteristics of the dementia in late-onset metachromatic leukodystrophy. Neurology 1994;44;662-5.
77. Hyde TM, Ziegler JC, Weinberger DR. Psychiatric disturbances in metachromatic leukodystrophy. Arch Neurol 1992;49:401-6.
78. Krivit W, Shapiro E, Kennedy W, Lipton M, Lockman L, Smith S, Summers C, Wenger D, Ramsey N, Kersey J, Yao JK, Kaye E. Effective treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation. NEngl J Med 1992;322:28-32.
79. Pridjian G, Humbert J, Willis J, Shapiro E. Presymptomatic late-infantile metachromatic leukodystrophy treated with bone marrow transplantation. J Pediatr 1994;l2J:755-8.
80. Navarro C, Fernandez JM, Dominguez C, Fachal C, Alvarez M. Late juvenile metachromatic leukodystrophy treated with bone marrow transplantation; a 4-year follow-up study. Neurology 1996;46:254-6.
81. Shapiro E, Lipton M, Krivit W. White matter dysfunction and its neuropsychological correlates: a longitudinal study of a case of metachromatic leukodystrophy treated with bone marrow transplant. J Clin Exp Neuropsychol 1992;14:610-24.
82. Wenger DA. Krabbe disease (globoid cell leukodystrophy). In Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, eds. The Molecular and Genetic Basis ofNeurological Disease. Boston, MA: Butterworth- Heinemann; 1997: 421-31.
83. Kolodny EH. Globoid leukodystrophy. In Moser HW, ed. Neurodystrophies and Neurolipidoses, vol. 66 of Handbook ofClinical Neurology. Amsterdam: Elsevier; 1996: 187-210.
84. Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe’s disease. N Engl J Med 2005;352:2069-81.
85. Escolar ML, Poe MD, Martin HR, Kurtzberg J. A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation. Pediatrics 2006;118:e879-89.
86. Krivit W, Shapiro EG, Peters C, Wagner J, Cornu G, Kurtzberg J, et al. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med 1998;338:1119-26.
87. Meikle PJ, Hopwood JJ, Clague AE, Carey, WF Prevalence of lysosomal storage disorders. J Am Med Assoc 1999;281:249-54.